Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Effect of Ginger Decoction Intervention on Nausea and Vomiting in First Trimester Pregnancy: A Literature Review Efendi, Melani Adelia; Bunga, Adelia; Ramadhani, Adinda Nasywa; Deviantony, Fitrio; Kurdi, Fahruddin
Jurnal Kesehatan Komunitas Indonesia Vol 5 No 2: August 2025
Publisher : Al-Hijrah Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58545/jkki.v5i2.386

Abstract

Introduction: During pregnancy, many mothers experience discomfort such as vomiting and nausea. During pregnancy, nausea and vomiting are common in Indonesia, with 50-75% of women experiencing symptoms in the first trimester or early pregnancy. Nausea and vomiting during pregnancy are caused by an increase in estrogen and human chorionic gonadotropin (HCG) hormone. Objective: To determine the effect of ginger decoction intervention on nausea and vomiting during pregnancy in the first trimester. Method: The method used is a literature review with a PRISMA protocol approach, with 6 journals found, 3 international, 3 nationals. The literature search process in this literature review uses 3 databases: PubMed, Google Scholar, and Science Direct, with a publishing period of 2019-2023. Results: Six research journals have shown that steeping ginger can reduce nausea and vomiting in pregnant women in the first trimester. Ginger has pharmacological effects as an antiemetic and can reduce the frequency of nausea and vomiting. The use of ginger can help pregnant women overcome the problem of nausea and vomiting during pregnancy. Conclusion: From the 6 studies obtained, it can be concluded that there is a significant effect of giving boiled ginger water as a nursing intervention in first-trimester pregnant women. As a complementary therapy, ginger water can effectively reduce the frequency of nausea and vomiting in pregnant women.
ANTIDIABETIC PROPERTIES OF TRADITIONAL INDONESIAN MEDICINAL PLANTS: A SCOPING REVIEW OF PRECLINICAL AND CLINICAL EVIDENCE ABSTRACT Wildana, Fahmi; Efendi, Melani Adelia; Trisna, Azhari; Mahmudi, Fikri Ali; Sitorus, Ulina Debora Junita Sitorus Debora Junita
INDONESIAN NURSING JOURNAL OF EDUCATION AND CLINIC (INJEC) Vol 11, No 1 (2026): INJEC
Publisher : Asosiasi Institusi Pendidikan Ners Indonesia (AIPNI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24990/injec.v11i1.1033

Abstract

Introduction: Diabetes mellitus (DM) poses a major global health burden, particularly in low- and middle-income countries where access to care and medication costs remain challenging. Indonesia, a biodiversity hotspot with extensive ethnomedicinal heritage, offers numerous traditional plants with potential antidiabetic properties. This study aimed to systematically map preclinical and clinical evidence on the antidiabetic activity of traditional Indonesian medicinal plants.Method: A scoping review was conducted using PubMed, Scopus, and Google Scholar databases (2015–2025). Studies were included if they evaluated Indonesian medicinal plants for antidiabetic effects in preclinical (in vitro/in vivo) or clinical settings. Screening followed the PRISMA-ScR framework, and methodological quality was assessed using the Joanna Briggs Institute (JBI) appraisal tools.Results: Twenty primary studies met the inclusion criteria (17 preclinical, 3 clinical). Preclinical studies consistently demonstrated reductions in blood glucose, improved insulin secretion and sensitivity, β-cell protection, and antioxidant effects. Notable species included Andrographis paniculata, Muntingia calabura, Artocarpus heterophyllus, Ocimum basilicum, and Gynura procumbens. Clinical trials involving cinnamon, ginger, and Momordica charantia showed moderate glycemic improvements (fasting blood glucose −6.3%, HbA1c −0.5%) but were limited by small sample sizes, heterogeneous extract preparations, and short durations.Conclusion: Indonesian traditional medicinal plants exhibit promising antidiabetic potential through multiple mechanisms and may serve as safe adjuvant therapies for diabetes management. However, clinical validation remains insufficient. Future research should emphasize large-scale randomized controlled trials with standardized extracts, extended intervention durations, and comprehensive outcome measures to support evidence-based integration into clinical practice.